Latest Operating Expenses News

Australian Agricultural Projects Ltd reports steady orchard health and harvest expectations amid rising water prices, while strengthening its asset base and maintaining robust cashflow in the December 2025 quarter.

Wrkr Ltd has transitioned from development to deployment, launching key products and acquiring PaidRight to expand its payroll compliance offerings ahead of new legislation.

Aeris Environmental Ltd has reported strong commercial momentum with its Syncromesh IoT platform and specialty chemicals, highlighted by initial orders from Budweiser APAC and a growing purchase order pipeline exceeding $800,000.

Freedom Care Group Holdings has placed its main operating entity into administration following a sharp decline in cash receipts linked to delayed payments from the NDIA and an ongoing audit. The company’s cash balance dropped significantly, prompting urgent restructuring efforts.

Appen Limited delivered a robust Q4 FY25, driven by explosive growth in its China segment and strong gains in generative AI projects globally, boosting revenue and profitability significantly.

Acrux Limited reports solid revenue growth and increased cash reserves in the December quarter, driven by expanding its topical generics portfolio in the US and strategic moves into female Hormone Replacement Therapy.

Helix Resources has launched significant geophysical surveys at its White Hills copper-gold project in Arizona and confirmed promising metallurgical results at its Gold Basin gold deposit, underpinning potential low-cost development. The company also completed a $2 million capital raise and secured permits for further sampling in New South Wales.

Tinybeans Group’s acquisition of US-based Qeepsake fuels a sharp revenue jump and improved profitability in Q2 FY26, signalling early success in its growth strategy.

Atomo Diagnostics reported a robust 121% quarter-on-quarter revenue increase to $1.5 million, driven by new orders for its FebriDx Pascal and HIV Self-Test products. The company also secured a global licensing deal for a novel liver function test and expanded manufacturing capacity to support growing demand.

Boss Energy Limited reported a robust quarterly cash flow for December 2025, ending with nearly A$53 million in unrestricted cash and positive operating inflows. The company maintained steady investment in exploration and infrastructure while keeping financing activities minimal.

Way2VAT Ltd has reported a record quarterly revenue of A$2.13 million for Q4 FY25, driven by strong client growth and strategic acquisitions, setting the stage for further expansion in 2026.

Following its December 2025 ASX debut and a successful IPO, Saluda Medical reports robust global revenue growth and expands its US sales force, prompting an upward revision of its FY26 revenue guidance.